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ABSTRACT
The regenerative effects of cardiac ckit+ stem cells (ckit+CSCs) in acute myocardial 
infarction (MI) have been studied extensively, but how these cells exert a protective 
effect on cardiomyocytes is not well known. Growing evidences suggest that in adult 
stem cells injury triggers inflammatory signaling pathways which control tissue 
repair and regeneration. Aim of the present study was to determine the mechanisms 
underlying the cardioprotective effects of ckit+CSCs following transplantation in a 
murine model of MI.
Following isolation and in vitro expansion, cardiac ckit+CSCs were subjected 
to normoxic and hypoxic conditions and assessed at different time points. These 
cells adapted to hypoxia as showed by the activation of HIF-1α and the expression 
of a number of genes, such as VEGF, GLUT1, EPO, HKII and, importantly, of alarmin 
receptors, such as RAGE, P2X7R, TLR2 and TLR4. Activation of these receptors 
determined an NFkB-dependent inflammatory and reparative gene response (IRR). 
Importantly, hypoxic ckit+CSCs increased the secretion of the survival growth factors 
IGF-1 and HGF. To verify whether activation of the IRR in a hypoxic microenvironment 
could exert a beneficial effect in vivo, autologous ckit+CSCs were transplanted into 
mouse heart following MI. Interestingly, transplantation of ckit+CSCs lowered 
apoptotic rates and induced autophagy in the peri-infarct area; further, it reduced 
hypertrophy and fibrosis and, most importantly, improved cardiac function.
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ckit+CSCs are able to adapt to a hypoxic environment and activate an 
inflammatory and reparative response that could account, at least in part, for a 
protective effect on stressed cardiomyocytes following transplantation in the infarcted 
heart.
INTRODUCTION
Myocardial infarction (MI) represents a leading 
cause of morbidity and mortality worldwide [1].
Although the ongoing therapeutic strategies, 
represented by prompt reperfusion of the ischemic 
myocardium, and pharmacological treatments, mainly 
based on anti-platelet agents, statins, ACE inhibitors 
and beta blockers [2], have contributed to decrease the 
mortality of patients, cardiac ischemia-reperfusion (I/R) 
injury and adverse remodeling still remain the major 
factors impairing cardiac function and determining an 
unsatisfactory prognosis [3]. A better understanding of 
the pathophysiology of these conditions could help in the 
identification of new therapeutic strategies.
MI is associated with a potent inflammatory 
response (reviewed in [4]). During cardiac ischemia, 
the shortage of oxygen and nutrients leads to the death 
of cardiomyocytes and endothelial cells [5] with the 
following passive release of endogenous damage-
associated molecular pattern molecules (DAMPs), also 
known as alarmins, that activate the local macrophages 
and promote the recruitment of leukocytes [6]. In the 
surviving cardiomyocytes and endothelial cells, as 
well as in the inflammatory cells, the post-MI hypoxic 
microenvironment induces the activation of the hypoxia 
inducible factor 1 alpha (HIF-1 α) [7], allowing the 
adaptation of these cells to the reduced oxygen level, and 
promoting the acquisition of an inflammatory reparative 
phenotype through the expression of a wide range of genes 
[8-11], among which the receptors for alarmins [12-17]. 
The binding of the alarmins their receptors determine the 
activation of the nuclear factor kappa-light-chain-enhancer 
of activated B cells (NFkB) and the expression of hundreds 
of genes involved in the inflammatory reparative response 
(IRR) [18] and accountable for the inflammatory cascade 
observed following the MI [19]. Of note, HIF-dependent 
adaptation and expression of proinflammatory genes has 
been also observed in hypoxic stem cells [20].
The observation that, in several other cardiac 
pathologies, the immune response was accountable 
for extended cardiac injury and accentuated adverse 
remodeling has led to the investigation of different 
strategies aimed to suppress the inflammatory response in 
post-MI. However due to the detrimental effects of these 
approaches on the cardiac function [21-24], treatments 
with broad immunosuppressive drugs have been largely 
abandoned. Results of these experiments indicated that 
the inflammatory response is necessary to eliminate debris 
and to initiate the reparative process, but it needs to be 
tightly regulated to prevent a pathological remodeling 
of the myocardium which may led to congestive heart 
failure. In particular, prolonged or excessive induction of 
proinflammatory signalling has been linked to apoptosis 
of cardiomyocytes, enhanced matrix-degrading processes 
and extended fibrotic changes beyond the initial infarct 
[25]. Hence, an effective therapy should not interfere with 
the activation of the inflammatory pathway but rather 
reduce the length and damage of the response.
In this study, we aimed to test the hypothesis that 
cardiac c-kit+ stem cells (ckit+CSCs), whose ability 
to modulate the inflammatory response was recently 
demonstrated [26], acquire an inflammatory phenotype 
under hypoxic conditions that could allow them to 
modulate the reparative response and reduce the damage 
in a hypoxic tissue, as the infarcted heart, following 
transplantation. In particular, in vitro, following hypoxia 
treatment, we observed a significant up-regulation of the 
IRR genes in ckit+CSCs. Further, after their injection in 
a mouse model of MI, we observed a reduced level of 
apoptosis together with an induction of autophagy and 
an attenuation in cardiac remodeling. These effects were 
associated to an improvement in cardiac performance.
RESULTS
Hypoxia regulates expression of pro-
inflammatory genes and proteins in ckit+CSCs
Several evidences suggest that in a hypoxic tissue, 
inflammation can be activated causing damage as well 
as repair. This response, named IRR, can occur in many 
important human pathologies and involve chiefly distant 
and resident leukocytes. Nevertheless, HIF-dependent 
adaptation and expression of pro-inflammatory genes has 
been also observed in hypoxic stem cells and progenitors 
[20].
To verify whether ckit+CSCs are able to adapt to a 
hypoxic environment by the IRR, these cells were cultured 
and incubated either in normoxia or hypoxia for 6, 24, and 
48 hours (h).
Importantly, in normoxic condition, ckit+CSCs 
examined in our study did not show any significant 
presence of leukocytes as shown by CD45 FACS analysis 
(Supplementary Figure 1). Hypoxia clearly influenced the 
expression of pro-inflammatory genes and proteins. HIF-1 
α mRNA expression was significantly increased following 
24h of hypoxia (Figure 1A) while its target gene VEGF 
significantly increased at all three time points but mainly 
at 24 and 48h (Figure 1B). Among the other HIF-1 α 
target genes, as showed by RT-PCR, the expression level 
of GLUT1 gradually increased from 6 to 48h (Figure 1C) 
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while erythropoietin (EPO) expression strongly increased 
at all three time points showing a peak after 24h of 
hypoxia (Figure 1D). Importantly, alarmin receptors such 
as RAGE, P2X7R, the Toll-like receptors 2 and 4 (TLR2 
and TLR4) were activated by hypoxia. The membrane 
receptor RAGE showed a transient induction at 6h and 
a low induction by hypoxia at 24 and 48h (Figure 2A). 
The expression of the other membrane receptor P2X7R 
was increased only following 48h of hypoxia (Figure 2B). 
TLR2 and TLR4 showed a similar expression pattern: a 
decrease at 6h and a significant increase both at 24 and 
48h (Figure 2C-2D).
The activation of these receptors resulted in 
increased expression levels of NFkB (Figure 2E) that 
led to the expression of genes belonging to the family 
of the IRR (all involved in defense, protection and 
repair of cells and tissues of the IRR as well) as the 
pro-inflammatory proteins cyclooxygenase-2 (COX2), 
the pentraxin-3 (PTX3), the chemokine (C-X-C motif) 
receptor 4 (CXCR4) and the nitric oxide synthase-2 
(NOS2). In particular, hypoxia increased the expression 
of the inducible enzymes COX2 (Figure 2F) and NOS2 
(Figure 2G) mainly at 48h but significantly at all three 
time points. Conversely, the expression of PTX3 was 
induced by hypoxic conditions only at 6h (Figure 2H). 
Finally, CXCR4 was induced by hypoxia at 48h (Figure 
2I). However, in all experimental conditions, we always 
observed an increased expression of the genes related to 
HIF-1 α and NFkB in CSCs under hypoxia compared to 
normoxia.
For several markers, increased protein expression 
levels were obtained by WB analysis under hypoxic 
conditions mainly at 24h (Figure 3A-3F).
In particular, hypoxia increased the expression 
of HIF-1 α at 24h (Figure 3A). Noteworthy, the protein 
expression of the transporter carbonic anhydrase 9 (CAR9) 
was slightly increased at 6 and 24h while the metabolic 
enzyme hexokinase 2 (HK2), regulated by HIF-1 α as 
CAR9, was significantly increased following 24h and 
48h of hypoxia (Figure 3B and 3C). The expression of 
COX2 and RAGE was increased after 24h of hypoxia but 
the expression of RAGE was significantly reduced after 
48h of hypoxia (Figure 3D and 3E). Hypoxia increased 
the expression of NFkB p65 subunit (NFkB p65) at 24h 
(Figure 3F) and, most importantly, induced its activation 
as showed in Figure 4G. Specifically, Western blot 
analysis showed that hypoxia induced the phosphorylation 
of cytoplasmic NFkB p65 within the first 30 min and 
Figure 1: Hypoxia enhances mRNA expression of HIF-1 α and its target genes in ckit+CSCs. Ckit+CSCs were incubated 
under normoxic or hypoxic conditions for 6, 24 and 48h. mRNA expression levels of (A) HIF-1 α, (B) VEGF, (C) GLUT1 and (D) EPO 
were determined by real time PCR. The bar graphs show fold increases in expression of the studied genes in ckit+CSCs with respect to 
control normoxic cells, set at 1. Data were normalized to GUSB, a housekeeping gene, and represent means ± SEM for three separate 
experiments, each repeated in triplicate. *, P < 0.05.
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its nuclear translocation in a time-dependent manner 
(Figure 3G).
ckit+CSCs enhance the production of IGF-1 and 
HGF under hypoxia conditions
ELISA assays were performed to measure the levels 
of two growth factors, both involved in cardioprotection, in 
the conditioned medium of normoxic and hypoxic ckit+CSCs. 
After 48h of hypoxia, we detected a significant increase in 
IGF-1 (Figure 4A) and HGF levels (Figure 4B) in conditioned 
media of hypoxic ckit+CSCs compared to normoxia.
ckit+CSCs enhance IL10 circulating levels and 
protein expression
Since activation of the IRR leads to protection and 
repair of damaged cells, we hypothesized that following 
transplantation into the infarcted myocardium, ckit+CSCs 
would exert a cardioprotective effect by activating 
this pathway. To test this hypothesis, ckit+CSCs were 
transplanted into the damaged heart of an ischemic mouse. 
Firstly, by Luminex assay, we detected circulating levels 
of different pro- and anti-inflammatory cytokines 3 days 
following surgery: we did not find significant differences 
Figure 2: Hypoxia enhances mRNA expression of NFkB and markers of the NFkB-dependent inflammatory and 
reparative response in ckit+CSCs. Ckit+CSCs were incubated under normoxic and hypoxic conditions for 6, 24 and 48h. mRNA 
expression levels for (A) RAGE, (B) P2X7R, (C) TLR2, (D) TLR4, (E) NFkB, (F) COX-2, (G) NOS2, (H) PTX3 and (I) CXCR4 were 
determined by real time PCR. The bar graphs show fold increases in expression of the studied genes in ckit+CSCs with respect to control 
normoxic cells, set at 1. Data were normalized to GUSB, a housekeeping gene, and represent means ± SEM for three separate experiments, 
each repeated in triplicate. *, P < 0.05.
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among injected infarcted hearts and control infarcted 
hearts except for IL10, a potent anti-inflammatory 
cytokine, that resulted significantly up regulated in the 
ckit+CSC treated group (Figure 5A). This result was 
confirmed by WB analysis on the infarcted region of 3 
day-infarcted hearts: we detected significantly enhanced 
expression levels of IL10 in ckit+CSC transplanted 
hearts compared to control hearts (Figure 5B). Further, 
Figure 3: Hypoxia enhances protein expressions of pro-inflammatory proteins in ckit+CSCs. Western blot analysis showing 
the expression of (A) HIF-1 α, (B) CAR9 and (C) HK2, (D) COX2 and (E) RAGE and (F) NFkB in ckit+CSCs under hypoxic conditions 
(H) at 6, 24 and 48h compared to normoxic conditions (N). The same filter was probed with anti-CDK4 pAb to show the equal loading. 
Left panel: A representative Western blotting of three independent experiments is shown. Right panel: Densitometric analysis of Western 
blot. Data are shown as means ± SEM. *P < 0.05 vs normoxic conditions (N). (G) Western blot analysis showing the expression of 
phospho-specific anti-NFkB p65, anti-NFkB p65, tubulin and histone H3. The analysis was performed using cytoplasmic (CE) and nuclear 
(NE) extracts prepared from ckit+CSCs under hypoxic conditions (H) at 15’, 30’, 60’ and 6h compared to normoxic conditions (N). A 
representative Western blotting of three independent experiments is shown.
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comparing the samples from the same groups of animals, 
we also detected an increased phosphorylation of STAT3 
following infarction and transplantation (Figure 5C).
ckit+CSCs improve cardiac function 2 weeks 
following MI
We investigated whether ckit+CSC transplantation 
was associated to an improvement in cardiac function 
following MI. These cells were injected in the border 
zone of mice immediately after the induction of MI. Mice 
receiving intramyocardial injection of PBS just after MI 
were used as controls. Hemodynamic measurements were 
performed 14 days after infarction. Ckit+CSC transplanted 
mice showed better preservation of myocardial function 
in comparison to control mice: left ventricular end 
diastolic pressure (LVEDP) was lower (11±4.2 mmHg 
vs 17±5.8 mmHg) (Figure 6), while both positive dP/dt 
(rate of pressure rise) and negative dP/dt (rate of pressure 
decay) were higher suggesting a less severe damage in the 
presence of treatment.
ckit+CSCs improve left ventricular remodeling
The functional improvement in ckit+CSC 
transplanted hearts was associated with reduced LV 
chamber diameter and volume (Figure 7A and 7B). 
The attenuation in ventricular dilation together with 
the hemodynamic parameters resulted in a reduction in 
diastolic free wall and septal wall stress (Figure 7C and 
7D). Further, Heart weight/Body weight ratio, an index of 
cardiac hypertrophy, was reduced in transplanted hearts 
compared to controls (Figure 7E).
ckit+CSCs attenuate hypertrophy in the infarcted 
murine heart
Hematoxylin-eosin (H&E) staining showed that 
the scar from ckit+CSC transplanted hearts displayed 
a better preservation compared with that from control 
hearts suggesting a beneficial effect of cell therapy 7 
days following MI (Figure 8A-8D). Further, markers of 
hypertrophy in the survived myocardium of both groups 
of mice were analyzed at a later time point. In particular, 
muscle LIM Protein (MLP), also known as cysteine rich 
protein 3 (CSRP3, CRP3), has a significant impact on 
cardiac muscle physiology and pathology. Specifically, in 
mice, reduced expression of CSRP3 leads to myocardial 
hypertrophy followed by dilated cardiomyopathy and heart 
failure [27]. In our experimental model, by WB analysis, 
we detected a higher expression level of CSRP3 in the 
border zone of 21 day-infarcted hearts following ckit+CSC 
transplantation compared to controls (Figure 8E).
Cardiac hypertrophy is characterized by a switch 
of expression from α-myosin heavy chain (α-MHC) 
to β-MHC [28, 29]. Following 21 days of cell therapy, 
we observed, in the border zone of infarcted hearts, the 
presence of lower levels of β-MHC and of higher levels of 
α-MHC, as showed by WB, leading to a marked decrease 
in MHC β-α ratio (Figure 8F).
ckit+CSCs reduce cardiac fibrosis following 
acute MI
TGF β is an indicator of cardiac fibrosis that plays an 
important role in the pathogenesis of cardiac remodeling. 
In our experimental model, 3, 7 and 21 days following 
ckit+CSC treatment, infarcted mice were characterized by 
circulating levels of TGF β1, detected by Luminex assay, 
significantly lower than that in controls suggesting an 
attenuation in adverse remodeling (Figure 9A).
In the infarcted murine heart, TGF β promotes 
myofibroblast transdifferentiation and matrix synthesis. 
Accordingly to our results on circulating TGF β1, we detected 
lower collagen deposition as showed by Azan –Mallory 
staining (Figure 9B-9D) and by a reduced protein expression 
of collagen I in the infarcted hearts 21 days following stem 
cell transplantation compared to control hearts (Figure 9E). 
Figure 4: IGF-1 and HGF levels increase in the conditioned medium of hypoxic ckit+CSCs. ELISA detection of (A) IGF-1, 
(B) HGF in in the conditioned medium of 48h normoxic and hypoxic ckit+CSCs (n= 3 independent experiments). Results are presented as 
means ± SD. *P < 0.001 vs normoxic conditions.
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Further, in order to account for these results, we evaluated 
whether hypoxic ckit+CSCs had any effect on the expression 
of matrix metalloproteinases (MMPs) and their inhibitors 
(TIMPs). 24h of hypoxia had no significant effects on 
MMP2 mRNA while it markedly enhanced MMP9 mRNA 
in ckit+CSCs (Figure 9F). Additionally, when we examined 
the mRNA expression of the MMP inhibitors, we found that 
TIMP4 was significantly lower in hypoxic ckit+CSCs than in 
normoxic cells (Figure 9G). In contrast, there was no effect 
on TIMP3 expression (Figure 9G).
Figure 5: ckit+CSCs enhance circulating levels and protein expression of IL10 in infarcted hearts following 
transplantation. (A) Circulating levels of pro- and anti-inflammatory cytokines detected by Luminex assay 3 days following surgery 
in the serum of PBS treated infarcted mice used as controls (MI, n=4) and ckit+CSC transplanted infarcted mice (MI+ckit+CSCs, n=4), 
all normalized for their relative sham controls. Data are shown as means ± SEM. *P<0.05 vs MI. Western blot analysis showing the 
expression of (B) IL10 and (C) phospho-STA3/STAT3 in the infarcted region of 3 day-infarcted heart following ckit+CSC transplantation 
(MI+ckit+CSCs, n=3). Infarcted hearts treated with PBS were used as control (MI, n=3). Left panel: A representative Western blotting of 
three independent experiments is shown. Right panel: Densitometric analysis of Western blot. Data are shown as means ± SEM. *P < 0.05 
vs untreated myocardial infarction (MI).
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ckit+CSCs reduce apoptosis and induce 
autophagy in vivo following acute MI
We verified the anti-apoptotic effect of transplanted 
ckit+CSCs 3 days following MI. Specifically, we evaluated 
caspase-3 cleavage by WB analysis in the border zone 
of infarcted hearts (Figure 10A). Treated hearts showed 
lower expression levels of cleaved caspase-3 compared 
to controls. Further, we also measured the expression 
levels of apoptotic downstream targets, including the anti-
apoptotic protein Bcl-2 as well as the pro-apoptotic protein 
Bax (Figure 10B-10C). Results showed that the protein 
expression of Bcl-2 was significantly increased in the 
border zone of 3 day-infarcted hearts by transplantation 
(Figure 10B). Conversely, cell treatment significantly 
inhibited Bax expression compared to the control group 
(Figure 10C).
Importantly, these results were confirmed by 
the measurement of apoptotic rate 7 days following 
MI and transplantation. Apoptosis in the peri-infarct 
region was significantly lower in transplanted animals 
compared to controls with nearly a 2 fold reduction 
in apoptotic rate (2.27 ± 0.22% vs 4.7 ± 0.84%, p= 
0.0052) as showed by quantification of apoptotic 
cardiomyocytes (Figure 10D).
Since recent studies have indicated a protective role 
of the autophagic process in ischemic heart disease [30, 31], 
we tested whether reduced apoptotic rate in the peri-infarct 
region of transplanted hearts was associated to increased 
autophagy. We firstly performed an immunofluorescence 
for the ubiquitin-like modifier LC3 (LC3). Results revealed 
that, 3 days following MI, the ckit+CSC transplanted group 
exhibited an higher number of cardiomyocytes with LC3 
punctate dots compared to the control group. To further 
confirm that autophagy was induced, we analyzed the 
expression of LC3 by WB analysis (Figure 11A). Results 
showed that, 3 days following MI, there was a significant 
increase in LC3 II formation in the border zone of ckit+CSC 
transplanted hearts compared to controls indicative of 
autophagosome formation. Further, the infarcted hearts 
were also characterized, following cell transplantation, by 
significant up-regulation of autophagy-related gene 7 (Atg7) 
protein level, another important protein for autophagosome 
formation (Figure 11B).
DISCUSSION
In the present study, we have demonstrated that 
cardiac ckit+CSCs adapt to hypoxia and acquire an 
inflammatory reparative phenotype through the expression 
Figure 6: Effects of ckit+CSCs on cardiac function. Functional assessment of myocardial function, hemodynamic parameters. 
LVEDP, LV +dP/dt (rate of pressure rise) and LV -dP/dt (rate of pressure decay) in sham-operated (SO) and infarcted mice treated either with 
PBS (MI) or ckit+CSCs (MI+ckit+CSCs). Measurements were obtained 14 days after myocardial infarction and ckit+CSC transplantation; 
Data represent means±SD (SO, n=8; MI, n=7; MI+ckit+CSCs, n=7; *p<0.05 vs SO; §p<0.05 vs MI).
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of HIF-1α and NFkB target genes and the release of growth 
factors. In vivo, following intramyocardial injection of 
these cells, ischemia adaptation led to cardioprotection 
of the infarcted myocardium. Specifically, ckit+CSC 
transplantation after acute MI lowered apoptosis, induced 
autophagy and attenuated adverse remodeling by reducing 
hyperthophy and fibrosis. These effects contributed to an 
improvement in cardiac performance.
Figure 7: ckit+CSCs improve left ventricular remodeling. (A) LV chamber diameter, (B) LV chamber volume, (C) diastolic free 
wall stress, (D) diastolic septal wall stress and (E) Heart weight/Body weight following MI. All measurements were obtained 2 weeks after 
ckit+CSC or PBS treatment. Results are presented as mean±SD (SO, n=7; MI, n=6; MI+ckit+CSCs, n=7; *p<0.05 vs SO; §p<0.05 vs MI).
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The regenerative capacity of cardiac ckit+CSCs 
in acute MI has been studied extensively but is highly 
debated [32, 33]. Currently, it is agreed that ckit+CSCs 
release paracrine factors that, rather than the cells 
themselves, stimulate endogenous regenerative pathways, 
thus promoting myocardial regeneration and improved 
Figure 8: ckit+CSCs attenuate hypertrophy following acute MI. Representative H&E stained myocardial sections (A-D) of 7 
day infarcted region from control (MI) (A) and ckit+CSC transplanted hearts (C). (B) and (D) represent high magnification of the insets 
shown in (A) and (C), respectively. The relative levels of (E) CSRP3 and (F) β-MHC/ α-MHC were investigated in the border zone of 
21 day-infarcted control hearts (MI, n=3) or ckit+CSC transplanted hearts (MI+ckit+CSCs, n=3) by Western blot (left panel) and relative 
densitometry of three independent experiments (right panel). Data are shown as means ± SEM. *P < 0.05 vs MI.
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cardiac function [34, 35]. Nevertheless, the molecular 
mechanism activated in these cells and responsible 
for their paracrine effect on cardiomyocytes following 
transplantation in the infarcted heart is not well known.
Following myocardial injury, necrotic 
cardiomyocytes release DAMPs that, in leukocytes, trigger 
innate immune signaling pathways [4] and activate NFkB, 
leading to the IRR, that is involved in the protection and 
Figure 9: ckit+CSCs reduce the expression of fibrotic markers. (A) Circulating levels of TGF β1 detected by Luminex assay 3, 
7 and 21 days following surgery in the serum of PBS treated infarcted mice used as controls (MI, n=4) and ckit+CSC transplanted infarcted 
mice (MI+ckit+CSCs, n=4), all normalized for their controls. Data are shown as means ± SEM. *P<0.05 vs MI. (B-D) Representative 
Azan-Mallory staining photomicrographs of control (MI) (B) and ckit+CSC transplanted infarcted hearts (MI+ckit+CSCs) (C, D) depicting 
fibrosis (blue area), 21 days after treatment. (D) represents high magnification of the insets shown in (C). (E) Collagen I expression in 
21 day-infarcted control hearts (MI, n=3) or ckit+CSC transplanted hearts (MI+ckit+CSCs, n=3) by Western blot (left panel) and relative 
densitometry of 3 independent experiments (right panel). Data are shown as means ± SEM. *P < 0.05 vs MI. (F) MMP2 and MMP9, (G) 
TIMP3 and TIMP4 mRNA expression by real time PCR in normoxic and hypoxic ckit+CSCs at 24h. Data were normalized to GUSB, a 
housekeeping gene and represent means ±SEM; Data were obtained from 3 independent experiments. *p< 0.02 vs normoxic ckit+CSCs.
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Figure 10: ckit+CSCs modulate the expression of apoptotic markers in treated infarcted hearts. Western blot analysis 
showing the expression of (A) cleaved-caspase 3, (B) Bcl-2 and (C) Bax, in the border zone of 3 day-infarcted control hearts (MI, n=3) 
or ckit+CSC transplanted hearts (MI+ckit+CSCs, n=3). Left panel: A representative Western blotting of three independent experiments 
is shown. Right panel: Densitometric analysis of Western blot. Data are shown as means ± SEM. *P < 0.05 vs MI. (D) Cardiomyocyte 
apoptosis measured by TdT assay. Bar graph showing apoptotic rate in the peri-infarct area of the myocardium of control (MI) and ckit+CSC 
transplanted infarcted (MI+ckit+CSCs) hearts. Data represent means±SD (MI, n=5; MI+ckit+CSCs, n=5; *p<0.0052 vs MI).
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repair of the injured tissue. Therefore, leukocytes play a 
critical role in regulating the inflammatory and reparative 
response that follows MI. In our in vitro model, we found 
that cardiac ckit+CSCs can activate a gene response similar 
to that present in activated leukocytes. Accordingly, 
hypoxic conditions induced in our cells the activation of 
HIF-1 α, allowing them to adapt to the reduced oxygen 
level through the transcription of angiogenic factors and 
the switch from oxidative to glycolytic metabolism [10, 
36]. Indeed, we detected an increased mRNA expression of 
VEGF and EPO following 6, 24 and 48 hours of hypoxia 
and a higher expression of GLUT1 and HK2. Interestingly, 
in a recent study, it has been demonstrated that, in vitro, 
treatment of bone marrow-derived angiogenic cells 
Figure 11: ckit+CSCs modulate the expression of autophagic markers in treated infarcted hearts. Representative images 
of immunofluorescence for LC3 (A) of heart tissue sections from 3 day-infarcted control hearts (MI) or ckit+CSC transplanted hearts 
(MI+ckit+CSCs). Left panel: green fluorescence indicates LC3 labeling. Central panel: orange fluorescence indicates SYTO 82 Orange 
Fluorescent staining of nuclei. Right panel: merge of both images. Western blot analysis showing the expression of (B) LC3 and (C) 
Atg7, in the border zone of 3 day-infarcted control hearts (MI, n=3) or ckit+CSC transplanted hearts (MI+ckit+CSCs, n=3). Left panel: A 
representative Western blotting of three independent experiments is shown. Right panel: Densitometric analysis of Western blot. Data are 
shown as means ± SEM. *P < 0.05 vs MI.
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(BMDACs) with an inducer of HIF resulted in a metabolic 
reprogramming of these cells as reflected by the increased 
expression levels of glucose transporters, metabolic 
enzymes and pH regulators [37]. These alterations in 
metabolism allowed the survival of pre-treated BMDACs 
in the ischemic hindlimb and strengthen the concept 
that metabolic and cell survival pathways are closely 
related [38]. For instance, it is increasingly recognized 
that HK2 functions also as a protective signaling 
molecule. Specifically, in the heart, cardiac-specific HK2 
overexpression prevents maladaptive hypertrophy by 
decreasing ROS accumulation [39]. In our experimental 
setting, we also found that hypoxia affects the expression 
of DAMP’s receptors. In particular, we observed that 
TLR2 and TLR4 were activated in ckit+CSCs after 24 and 
48h of treatment and RAGE showed a significant mRNA 
up-regulation mainly after 6h of hypoxia and increased 
expression of protein levels at 24 and 48h.
The receptors for DAMPs, firstly localized in tissue 
resident leukocytes [40, 41], and later described in many 
other cells and tissues, under stress conditions, can be 
induced and expressed de novo in resident or recruited 
stem cells and pluripotent undifferentiated progenitors 
from tissues [42, 43]. For instance, mesenchymal stem 
cells (MSCs) express TLRs [44, 45] and upon their 
stimulation, paracrine factors are released and may boost 
or reduce their immunosuppressive capacities [46]. In 
the setting of I/R injury, two different studies suggested 
that TLR2 presence and activation on injected MSCs 
could be essential for myocardial recovery [47] while 
TLR4 activation would have deleterious effects [48]. 
Nevertheless, it should be noted that since both studies 
used an I/R injury in an isolated rat heart model, no 
immune system was present and therefore the effect of 
TLR2 and TLR4 activation on immunomodulation by 
MSC remains unclear.
Interestingly, in a prior study, we have already 
demonstrated that cardiac ckit+ cells express RAGE and 
their regenerative responses, elicited by intramyocardial 
injection of exogenous High Mobility Group Box-1 
protein (HMGB1) following acute MI, are mediated, at 
least in part, by the interaction HMGB1-RAGE [49].
Our findings have shown a significant up-regulation 
of P2X7R mRNA in ckit+CSCs 48h following hypoxia. 
The purinergic P2X7R is involved in the migration and 
differentiation of different stem cells [50-52] and represents 
an essential pro-survival signal in embryonic stem cells 
[53]. In a model ex vivo of rat heart, agonists of this 
receptor are responsible for the release of cardioprotectants 
by ischemic pre- and post-conditioning [54].
Moreover, we observed that the mRNA expression 
levels of the inducible enzymes COX2 and NOS2 were up-
regulated by hypoxia at all three time points in ckit+CSCs 
and that COX-2 protein expression was increased 
following 24h of hypoxia. Interestingly, Dr. Bolli’s group, 
using a molecular genetic approach and a model of MI, 
has demonstrated that the cardioprotection afforded by 
NOS2 gene therapy is mediated by COX2 up-regulation 
via NFkB activation [55]. In particular, up-regulation of 
COX2 determines an increase in myocardial production 
of two cytoprotective prostanoids [56].
The long pentraxin PTX3 is expressed in the heart 
under inflammatory conditions and has a cardioprotective 
role in acute myocardial infarction in mice [57]. More 
recently, it has been demonstrated that PTX3 deficiency 
is associated with increased atherosclerosis, macrophage 
accumulation and inflammation in the atherosclerotic 
lesions suggesting a modulation by PTX3 of the vascular 
associated inflammatory response [58]. Together these 
observations support the possibility that PTX3 may exert 
a cardiovascular protective effect through the modulation 
of the immunoinflammatory balance. Our results showed 
that PTX3 expression is influenced by hypoxia only at the 
earliest time point following hypoxia.
Finally, we detected a significant up-regulation of 
the receptor for CXC chemokines CXCR4 in ckit+CSCs 
after 48h of hypoxia. Hypoxic preconditioning of ckit+ 
cardiac progenitor cells improves their survival following 
MI [59] by inducing CXCR4 expression. Further, CXCR4 
overexpression in MSCs attenuates cardiac remodeling 
after MI and this cardioprotective effect is mediated by 
the release of the antifibrotic enzyme MMP9 [60]. It is 
noteworthy that in our in vitro experiments, we detected 
a significant increase in the mRNA expression of MMP9 
and a significant decrease in the mRNA expression of the 
MMP inhibitor TIMP4 in hypoxic ckit+CSCs compared to 
normoxic cells.
The activation of NFkB mounts a regenerative 
response by inducing genes that encode growth factors 
with the potential to mediate different cardioprotective 
effects. Our cells secreted high levels of IGF-1 and HGF 
under hypoxic conditions. These secreted paracrine factors 
have been demonstrated to exert beneficial effects on cell 
survival and cardiac remodeling. For instance, myocardial 
injury induced by cardiotoxin injection in transgenic mice 
with cardiac-restricted mIGF-1 expression determined 
restoration of cardiac function [61]. This effect was 
mediated, in part, by modulation of the inflammatory 
response. Specifically, the mRNA of IL10, a potent anti-
inflammatory cytokine, was found to rapidly increase in 
transgenic hearts 24 hours after cardiac injury and this 
increase was even higher at 1 week [61]. It should be noted 
that IL10 has been showed to attenuate left ventricular 
remodelling after MI by reducing inflammation-mediated 
fibrosis [62]. Most importantly, transplantation of bone 
marrow mononuclear cells in infarcted mouse hearts 
led to the secretion of significant amounts of IL10 that 
were associated to decreased reactive hypertrophy and 
myocardial collagen deposition. These effects resulted 
in a significant improvement in cardiac function [63]. 
Interestingly, in our in vivo model, we detected higher 
levels of circulating IL10 in mice at 3 days following 
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ckit+CSC transplantation compared to controls and, at 
the same time point, this result was confirmed by IL10 
enhanced protein expression in the infarcted treated hearts. 
Further, in these mice, we also detected an increase in 
the phosphorylation of STAT3 whose signaling has been 
involved in IL10-mediated improvement in heart function 
in the MI model [62]. In the same mice, at 3 days but 
also at later time points, we also found decreased levels of 
circulating TGF β1 and, at 1 week, a reduced expression 
of collagen I in the border zone of treated infarcted 
hearts. The attenuation in LV remodeling in transplanted 
infarcted hearts compared to controls was also supported 
by up-regulation of CSRP3 and down-modulation of the 
β-MHC/α-MHC ratio, both indicative of a decrease in 
hypertrophy [64-66]. All these results were confirmed by 
an attenuated LV chamber dilation and wall stress in the 
heart of ckit+CSC transplanted mice compared to controls.
IL10 negatively affects cardiac remodelling also by 
attenuating apoptosis [67]. These data are in accordance 
with our results that showed the induction of autophagy 
and the reduction of apoptotic rate in infarcted hearts 3 
and 7 days after ckit+CSC transplantation, respectively. 
Importantly, an antiapoptotic effect on cardiomyocytes 
is also exerted by HGF [68] and transplantation of 
MSCs overexpressing HGF in a mouse model of MI was 
associated with less cardiomyocyte apoptosis [69].
As previously discussed, growing evidence suggests 
that stem cell therapy following MI could improve cardiac 
function not by differentiation into cardiomyocytes 
and vascular cells but most likely by the production of 
paracrine factors which have beneficial effects [35] and 
could influence the immune system. In particular, it has 
been demonstrated by several reports that stem cell therapy 
could activate a subset of reparative macrophages [70]. 
For instance, transplantation of MSCs into the infarcted 
heart contribute to the recovery of cardiac function, in 
part, by switching macrophages from a pro-inflammatory 
to an anti-inflammatory and reparative phenotype through 
secreted factors such as IGF-1 and IL10 [46, 71-73]. 
Thus, a possible scenario is that ckit+CSCs, following 
transplantation in a hypoxic environment as the infarcted 
heart, exert cardioprotective effects by modulating the 
activation of macrophages via a paracrine mechanism. 
Indeed, in a very recent paper, it has been postulated that 
cardiac ckit+ progenitors originate from a cardiac myeloid 
lineage, i.e. macrophage progenitor cells [74] suggesting 
the potential of ckit+ progenitors to display functional 
characteristics of macrophages. Importantly, the beneficial 
effects of ckit+CSC treatment were confirmed by enhanced 
cardiac function.
In conclusion, in this study we have showed that 
cardiac ckit+CSCs adapt to a hypoxic environment through 
the activation of pathways similar to that one present in 
leukocytes and activate a reparative response that leads to 
the release of different paracrine factors.
MATERIALS AND METHODS
Animal model and in vivo study
Myocardial infarction (MI) was induced by 
coronary artery ligation in BalbC female mice 8 weeks 
old (20 gr body weight), as previously described [49]. 
Briefly, thoracotomy via the third left intercostal space 
was performed in mice under anesthesia (100 mg/kg 
ketamine and 1mg/kg acepromazine) and mechanically 
ventilated. Then the left coronary artery was ligated 
and 5X104 ckit+CSCs cells in 10 μL PBS solution were 
injected through a 32-gauge needle. Four injections (2.5 
μL per injection) were performed in the ventricular wall 
bordering the viable myocardium. Control infarcted mice 
were injected with 10 μL of PBS. Sham operated mice 
were treated similarly, except that the ligature around the 
coronary artery was not tied. Animals were sacrificed 3, 7, 
14 and 21 days after surgery.
Hearts were processed in 4 different ways: 1) hearts 
were excised and the border and infarcted regions of 
infarcted mice were collected and stored at –80°C to be 
processed for protein extraction; specifically, the infarcted 
area was recognized as a pale zone caused by gross necrosis 
of the myocardium, due to interruption of the blood supply 
to the area while the border zone was identified as the 
area between the end of necrosis and the septum; 2) the 
abdominal aorta was cannulated and the heart was arrested 
in diastole with CdCl2, perfused retrogradely with 10% (vol/
vol) formalin, embedded in paraffin and sectioned (3 μm 
thickness); 3) hearts were excised, perfused with Tyrode 
solution to remove blood and frozen in liquid nitrogen. 
Cryosections (5 μm thickness) were air-dried for 20 min; 
4) the hearts of mice that did not undergo any surgery 
were used to isolate cardiac-derived cells by collagenase 
digestion of the left ventricle (LV).
All experimental procedures complied with the 
Guidelines of the Italian National Institutes of Health, with 
the Guide for the Care and Use of Laboratory Animals 
(Institute of Laboratory Animal Resources, National 
Academy of Sciences, Bethesda, MD) and were approved 
by the Institutional Animal Care and Use Committee.
Evaluation of myocardial function
For hemodynamic studies, mice were anesthetized 
with chloral hydrate (400 mg/kg body weight) and the 
right carotid artery cannulated with a microtip pressure 
transducer (Millar 1.4F) [49].
Cell isolation and culture
Cardiac-derived cells were isolated from BalbC 
female mice at 2–3 months of age by collagenase digestion 
(280 U/mL; Worthington, Lakewood, N.J., USA) through 
the coronary arteries and myocyte were removed by 
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centrifugation. Cells were cultured in F12:DMEM 
1:1 supplemented with 10% fetal bovine serum and 
expanded. Ckit+ cells were selected with immunomagnetic 
CD117 microbeads, mouse (Miltenyi Biotec) 
(Supplementary Figure 2) and were expanded in Ham’s 
F12 medium supplemented with 10% fetal bovine serum 
(FBS), penicillin-streptomycin and Erythropoietin (Sigma-
Aldrich) 2,5 mg in 500 ml [75].
Hypoxia
Hypoxic conditions were achieved by incubating 
ckit+CSCs in a humidified incubator Galaxy 14S (Eppendorf) 
at 37 °C with 5% CO2 and 1% O2 for 6, 24 and 48 h.
FACS analysis
For FACS analysis, ckit+CSCs were fixed in 4% 
paraformaldehyde for 15 minutes at room temperature 
and incubated with anti-CD45 antibody (BD Pharmingen) 
or anti-ckit antibody (Santa Cruz). Isotype control 
was performed (mouse polyclonal IgG; Santa Cruz 
Biotechnology). Specifically, cells were incubated with the 
primary antibody for 45 minutes at 37°C. Flow cytometry 
was performed with FACSAria (Becton Dickinson, San 
Jose, CA) instrument. Cellular debris and aggregates were 
gated out based on forward and side scatter. Gating on the 
signal of the nuclear stain DAPI was employed to exclude 
additional artifacts. Isotype-matched negative controls 
were utilized to define the threshold for each specific 
signal and establish the appropriate gate for positive cells. 
Data were analyzed with Kaluza Flow Cytometry Analysis 
software [76].
mRNA isolation and real time RT-PCR
Total RNA was extracted from ckit+CSCs 
following 6, 24 and 48h of normoxia and hypoxia (n=3/
group). Quality of RNA was checked using the Agilent 
2100 Bioanalyzer and nanodrop 1000. Then mRNA 
was quantified with ABI Prism 7000 SDS (Applied 
Biosystems). Real-time RT-PCR amplification was 
carried out in the 7900 Real-time PCR system (Applied 
Biosystems, CA, USA) using Real Time SyBr Green 
qPCR Superscript (Invitrogen, Milan, Italy). All reactions 
were carried out in triplicate. Relative expression was 
calculated using the comparative Ct method (2–[delta] 
[delta] Ct) [77]. The mean was calculated, and possible 
significant differences were analyzed using Student’s t 
test. P < 0.05 was considered significant.
The primers used are reported in Supplementary 
Table 1.
Western blot analysis
Proteins from cardiac tissue or ckit+CSCs were 
homogenized and extracted with RIPA buffer (10 mM Tris-
HCl pH 7.4, 150 mM NaCl, 1% NP40, 1% Deoxycolic 
acid, 0.1% SDS and 10% Glycerol) containing proteases 
and phosphatases inhibitors (2 mM phenylmethylsulfonyl 
fluoride, 100 U/ml of aprotinin, 10 μg/ml of leupeptin and 
pepstatin, 10 mM sodium fluoride, 20 mM sodium vanadate).
To separate cytoplasmic and nuclear fractions, 
cells were isolated using the nuclear exctraction kit from 
Active Motif (Carlsbad, CA), following manufacturer’s 
instructions. Briefly, cell were scraped off the plate in a 
phosphate–buffered saline/phosphatase inhibitor buffer 
using a rubber policeman. Cells were centrifuged 5 min 
at 500 rpm at 4°C and the supernatant discarded. The 
cell pellet was lysed in hypotonic buffer for 15 min in ice 
followed by centrifugation (30 s at 14 000 rpm at 4°C). 
The supernatant (cytosolic fraction) was transferred to a 
new tube, whereas the pellet (nuclear fraction) was lysed 
in a lysis buffer in the presence of protease inhibitors. 
Protein concentration of the fractions was determined by 
the Bradford assay (Bio–Rad, Hercules, CA).
Equal amounts of total cellular proteins (100 
μg/lane) were resolved by SDS-polyacrylamide gel 
electrophoresis and transferred to nitrocellulose membrane 
(Amersham Pharmacia Biotech, Little Chalfont, UK). 
Membranes were probed with rabbit monoclonal anti 
HIF-1 α (Cell Signaling Technology, Danvers, MA), 
goat polyclonal anti HXK2 (Santa Cruz Biotechnology, 
Dallas, TX) rabbit polyclonal anti CAIX (Thermo Fisher 
Scientific, Whaltam, MA), rabbit polyclonal anti NFkB 
p65 (Santa Cruz Biotechnology), rabbit monoclonal 
Phospho–NFkB p65 (Cell Signaling Technology, rabbit 
monoclonal anti COX2 (Cell Signaling Technology), 
goat polyclonal anti RAGE (Santa Cruz Biotechnology), 
goat polyclonal anti CXCR4 (Santa Cruz Biotechnology), 
goat polyclonal anti alfa-MHC and mouse monoclonal 
anti beta-MHC (Santa Cruz Biotechnology), mouse 
monoclonal anti CSRP3 (Santa Cruz Biotechnology), 
rabbit polyclonal anti collagen I (Abcam, Cambridge, 
UK), rabbit polyclonal anti LC3B (Novus Biologicals, 
Littleton, CO), rabbit polyclonal anti Cdk4 (Santa Cruz 
Biotechnology), rabbit monoclonal anti Atg7 (Cell 
Signaling Technology), rabbit polyclonal anti Bax 
(Santa Cruz Biotechnology), rabbit polyclonal anti 
Cleaved Caspase-3 (Cell Signaling Technology) mouse 
monoclonal anti Bcl-2 (BD Biosciences Pharmingen, 
Sparks, MD), mouse monoclonal anti IL-10 (Santa 
Cruz Biotechnology), rabbit monoclonal anti Stat3 
(Cell Signaling Technology) and rabbit polyclonal anti 
phosphor-Stat3 (Tyr705) (Cell Signaling Technology), 
followed by horseradish peroxidase-coupled secondary 
antibodies and developed by a chemiluminescence-based 
detection system (ECL, Amersham Pharmacia Biotech.).
Blood sample collection and Luminex assay
Whole blood was collected just prior to euthanasia 
3, 7 and 21 days after surgery in a 2ml polypropylene tube. 
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After collection, the blood was allowed to clot by leaving 
it undisturbed at room temperature. The clot was removed 
by centrifuging at 2500 rpm (600 x g) for 15 minutes in 
a refrigerated centrifuge. The resulting supernatant was 
designated as serum. Following centrifugation, serum was 
immediately transferred into a clean tube. The sample was 
maintained at 2–8°C while handling. The previous step 
was repeated 2-3 times, until the serum appeared clear 
(without any trace of hemolyzed red blood cells). Serum 
was aliquoted and stored at -80°C for Luminex assay.
Cytokines were measured by Luminex technology 
using a customized panel by the Bio-Plex Pro Mouse 
Cytokine 23-plex, Group I (to analyze the following: 
IL-2, IL-4, IL-5, IL-10, IL-12p40, IL-17A, GM-CSF, 
INF- γ, TNF-α). The analysis was performed using 50 
μl of the sample as manufacturer’s instruction. After the 
incubation with antibodies-activated magnetic beads, 
samples were washed using a Bio-Plex Pro TM Station 
(Bio-Rad) as described [78]. TGF β1 protein was analyzed 
using a Bio-Plex Pro TGF β assay (BioRad) according 
to manufacturer’s instructions with few modifications. 
Briefly, 12.5 μl of sample were first treated with 2.5 
μl of 1N HCl, then neutralized using 2.5 μl of 1.2 N 
NaOH/0.5M HEPES. Samples were analyzed using a 1:16 
final dilution. Then, they were incubated with antibodies-
activated magnetic beads and washed using a Bio-Plex Pro 
TM Station (Bio-Rad). The quantification was carried out 
by using a Bio-Plex Array Analyzer (Bio-Rad) and with 
Bio-Plex Manager Software version 6.1. Results were 
expressed as pg/ml.
Cardiac anatomy
After hemodynamic measurements, the abdominal 
aorta was cannulated, the heart was arrested in diastole 
and the left ventricular (LV) chamber was fixed at a 
pressure equal to the in vivo measured end-diastolic 
pressure. The LV intracavitary axis was measured, and 
three transverse slices from the base, mid-region and apex 
were embebbed in paraffin. The mid-section was used 
to measure LV thickness, chamber diameter and volume 
as described [49]. The chamber volume was calculated 
using the minimal and maximal luminal diameters at 
midregion with the longitudinal axis. Diastolic wall stress 
was determined from the wall thickness, chamber radius 
and left ventricular end diastolic pressure (LVEDP). Heart 
weight/Body weight ratio was also calculated. Tissue 
specimens were embedded in paraffin and sections were 
obtained for immunohistochemical studies.
Hematoxylin-eosin (H&E) and Azan–Mallory 
staining
For hematoxylin-eosin (H&E) staining, murine 
sections were deparaffinized, rehydrated, placed first 
in haematoxylin and then in eosin for 5 minutes each, 
dehydrated and finally mounted. Several transverse 
sections were stained with Azan–Mallory to detect 
myocardial fibrosis.
TUNEL assay
Terminal deoxynucleotidyltransferase (TdT)-
mediated dUTP nick end labeling (TUNEL) assay was 
used for the detection of apoptosis [79] with ApoAlert 
DNA fragmentation kit (Clontech), following the protocol 
for formalin-fixed, paraffin embedded tissue sections 
mounted on glass slides. Briefly, 3 μm thickness sections 
were dewaxed in xylene, hydrated and rinsed in PBS. 
After paraffin removal, the slides were immersed in 0.85% 
NaCl and incubated at room temperature for 5 min, fixed 
in 4% formaldehyde/PBS (room temperature for 15 min) 
and washed twice in PBS. A rapid incubation in a 20 μg/ml 
Proteinase K solution (3-5 min) was performed and then 
sections were fixed again in 4% formaldehyde/PBS (this 
time, room temperature for 5 min). After that, sections 
were equilibrated using an equilibration buffer (room 
temperature for 10 min) and incubated in TdT incubation 
buffer (containing Nucleotide mix and TdT enzyme) for 1 
h at 37°C in the dark. The tailing reaction was terminated 
by 2X SSC (room temperature for 15 min).
Nuclei were identified using SYTO 82 orange 
fluorescent nucleic acid staining (Molecular Probes, USA). 
Coverslips were mounted on anti-fade mountant (ProLong 
Diamond Antifade Mountant, Life Technologies) and 
sections were analyzed with a Zeiss microscope equipped 
for fluorescence.
Apoptotic rate defined the number of apoptotic 
cardiomyocytes on all cardiomyocytes per field. In order 
to avoid potential confounders deriving from the selection 
of fields with abnormal cardiomyocyte density, fields for 
the apoptotic rate count were selected in the peri-infarct 
area, defined as the zone bordering the infarct only where 
viable myocardium was prevalent and reparative fibrosis 
only marginal. Apoptotic rate in the peri-infarct region was 
calculated on 10 random fields, which virtually cover the 
entire peri-infarct area [80].
Immunofluorescence analysis
For immunofluorescence, frozen tissue sections 
from the left ventricle were stained with a rabbit 
polyclonal anti LC3B (Novus Biologicals, Littleton, CO). 
Nuclei were identified using SYTO 82 orange fluorescent 
nucleic acid staining (Molecular Probes, USA). The cover-
glasses were mounted and sections were analyzed with a 
LSM 510 confocal microscopy (Zeiss).
ImmunoSorbent assay-ELISA
ELISA analysis for mouse IGF-1 and HGF (R&D 
Systems, Minneapolis, USA) were performed following 
the manufacturer’s instructions.
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Data collections and statistics
Results are presented as means ± error standard or 
mean±SD when specified. Statistical significance between 
two measurements was evaluated by unpaired Student’s t 
test and multiple comparisons was performed using 1-way 
analysis of variance and the Tukey test. A probability value 
of p<0.05 was considered significant. Data were analyzed 
using Prism software (version 7.0, GraphPad, San Diego, 
California).
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